Literature DB >> 29978577

Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia.

Hanny Al-Samkari1, David J Kuter1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29978577     DOI: 10.1111/bjh.15432

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal:  Blood Adv       Date:  2019-11-26

2.  Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia.

Authors:  Xiaofang Tu; Ali Xue; Suye Wu; Mengmeng Jin; Pu Zhao; Hao Zhang
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

3.  Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.

Authors:  Hanny Al-Samkari; Debbie Jiang; Terry Gernsheimer; Howard Liebman; Susie Lee; Matthew Wojdyla; Michael Vredenburg; Adam Cuker
Journal:  Br J Haematol       Date:  2022-02-18       Impact factor: 8.615

Review 4.  Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease.

Authors:  Abraham Z Cheloff; Hanny Al-Samkari
Journal:  J Blood Med       Date:  2019-09-05

Review 5.  Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice.

Authors:  Fei Song; Hanny Al-Samkari
Journal:  J Blood Med       Date:  2021-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.